M Gaglani

Summary

Affiliation: Scott and White Memorial Hospital
Country: USA

Publications

  1. pmc Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons
    Lisa A Jackson
    Group Health Research Institute, Seattle, Washington, USA
    BMC Infect Dis 10:71. 2010
  2. doi request reprint Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial
    Manjusha J Gaglani
    Section of Pediatric Infectious Diseases, Department of Pediatrics, Scott and White Memorial Hospital and Clinic, Texas A and M University Health Science Center College of Medicine, Temple, TX 76508, USA
    Pediatr Infect Dis J 27:444-52. 2008
  3. ncbi request reprint A computerized reminder strategy is effective for annual influenza immunization of children with asthma or reactive airway disease
    M Gaglani
    Scott and White Memorial Hospital and Clinic, Scott, Sherwood and Brindley Foundation, Texas A and M University System Health Science Center College of Medicine, Temple, TX, USA
    Pediatr Infect Dis J 20:1155-60. 2001
  4. ncbi request reprint Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children
    Manjusha J Gaglani
    Section of Pediatric Infectious Diseases, Department of Pediatrics, Scott and White Memorial Hospital and Clinic, The Texas A and M University System Health Science Center College of Medicine, Temple, 76508, USA
    Arch Pediatr Adolesc Med 158:65-73. 2004
  5. ncbi request reprint Rationale and approach to target children with asthma for annual influenza immunization
    Manjusha J Gaglani
    Section of Pediatric Infectious Diseases, Scott and White Memorial Hospital and Clinic, Scott, Sherwood and Brindley Foundation, Texas A and M University System Health Science Center College of Medicine, Temple, TX, USA
    Semin Pediatr Infect Dis 13:97-103. 2002
  6. ncbi request reprint Every nose counts: a new influenza vaccine for all healthy schoolchildren?
    Manjusha J Gaglani
    Section of Pediatric Infectious Diseases, Scott and White Memorial Hospital Clinic, Scott, Sherwood and Brindley Foundation, Texas A and M University System Health Science Center College of Medicine, Temple, Texas 76508, USA
    Clin Pediatr (Phila) 43:35-41. 2004
  7. ncbi request reprint Effectiveness of school-based influenza vaccination
    James C King
    Department of Pediatrics, University of Maryland School of Medicine, 737 W Lombard St, Baltimore, MD 21201, USA
    N Engl J Med 355:2523-32. 2006
  8. ncbi request reprint Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures
    M Elizabeth Halloran
    Department of Biostatistics, Rollins School of Public Health, Emory University, 1518 Clifton Road NE, Atlanta, GA 30322, USA
    Am J Epidemiol 158:305-11. 2003
  9. pmc Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004
    M Elizabeth Halloran
    Program in Biostatistics and Biomathematics, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Vaccine 25:4038-45. 2007
  10. ncbi request reprint Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children
    Pedro A Piedra
    Baylor College of Medicine, Department of Molecular Virology and Microbiology, Room 248E, One Baylor Plaza, Houston, TX 77030, USA
    Pediatrics 120:e553-64. 2007

Collaborators

Detail Information

Publications12

  1. pmc Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons
    Lisa A Jackson
    Group Health Research Institute, Seattle, Washington, USA
    BMC Infect Dis 10:71. 2010
    ..The aim of this study was to assess the efficacy, safety, reactogenicity, and immunogenicity of a trivalent inactivated split virion influenza vaccine (TIV) in healthy adults over two influenza seasons in the US...
  2. doi request reprint Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial
    Manjusha J Gaglani
    Section of Pediatric Infectious Diseases, Department of Pediatrics, Scott and White Memorial Hospital and Clinic, Texas A and M University Health Science Center College of Medicine, Temple, TX 76508, USA
    Pediatr Infect Dis J 27:444-52. 2008
    ..Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with asthma is unknown. A previous report showed an "asthma signal" in children aged 18-35 months...
  3. ncbi request reprint A computerized reminder strategy is effective for annual influenza immunization of children with asthma or reactive airway disease
    M Gaglani
    Scott and White Memorial Hospital and Clinic, Scott, Sherwood and Brindley Foundation, Texas A and M University System Health Science Center College of Medicine, Temple, TX, USA
    Pediatr Infect Dis J 20:1155-60. 2001
    ..Annual influenza immunization is recommended for children with chronic conditions, including those with asthma or reactive airway disease (RAD); however, <10% receive it each year...
  4. ncbi request reprint Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children
    Manjusha J Gaglani
    Section of Pediatric Infectious Diseases, Department of Pediatrics, Scott and White Memorial Hospital and Clinic, The Texas A and M University System Health Science Center College of Medicine, Temple, 76508, USA
    Arch Pediatr Adolesc Med 158:65-73. 2004
    ....
  5. ncbi request reprint Rationale and approach to target children with asthma for annual influenza immunization
    Manjusha J Gaglani
    Section of Pediatric Infectious Diseases, Scott and White Memorial Hospital and Clinic, Scott, Sherwood and Brindley Foundation, Texas A and M University System Health Science Center College of Medicine, Temple, TX, USA
    Semin Pediatr Infect Dis 13:97-103. 2002
    ..An annual, well-organized, computerized multicomponent strategy should be implemented for optimizing influenza immunization in the high-risk population. Children with asthma should be targeted for annual influenza immunization...
  6. ncbi request reprint Every nose counts: a new influenza vaccine for all healthy schoolchildren?
    Manjusha J Gaglani
    Section of Pediatric Infectious Diseases, Scott and White Memorial Hospital Clinic, Scott, Sherwood and Brindley Foundation, Texas A and M University System Health Science Center College of Medicine, Temple, Texas 76508, USA
    Clin Pediatr (Phila) 43:35-41. 2004
    ..Could protection of healthy schoolchildren against influenza limit its spread and benefit society?..
  7. ncbi request reprint Effectiveness of school-based influenza vaccination
    James C King
    Department of Pediatrics, University of Maryland School of Medicine, 737 W Lombard St, Baltimore, MD 21201, USA
    N Engl J Med 355:2523-32. 2006
    ..Vaccination of children in school is one strategy to reduce the spread of influenza in households and communities...
  8. ncbi request reprint Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures
    M Elizabeth Halloran
    Department of Biostatistics, Rollins School of Public Health, Emory University, 1518 Clifton Road NE, Atlanta, GA 30322, USA
    Am J Epidemiol 158:305-11. 2003
    ..CAIV-T provides substantial protection against a mixture of influenza A (H1N1) and B. Results demonstrate the powerful potential of using validation sets for outcomes in vaccine field studies...
  9. pmc Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004
    M Elizabeth Halloran
    Program in Biostatistics and Biomathematics, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Vaccine 25:4038-45. 2007
    ..LAIV-T was cross-protective with a drift variant strain in 2003-2004, evidence that such vaccines could be important for preparing for a pandemic and for annual influenza...
  10. ncbi request reprint Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children
    Pedro A Piedra
    Baylor College of Medicine, Department of Molecular Virology and Microbiology, Room 248E, One Baylor Plaza, Houston, TX 77030, USA
    Pediatrics 120:e553-64. 2007
    ..The objective of this study was to determine the effectiveness of influenza vaccines for healthy school-aged children when administered during the influenza outbreak...
  11. ncbi request reprint Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children
    Pedro A Piedra
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Rm 248E, One Baylor Plaza, Houston, TX 77030, USA
    Vaccine 23:1540-8. 2005
    ..Vaccination of approximately 20-25% of children, 1.5-18 years of age in the intervention communities resulted in an indirect protection of 8-18% against MAARI in adults > or =35 years of age...
  12. pmc Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial
    Pedro A Piedra
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030, USA
    Pediatrics 116:e397-407. 2005
    ....